...
首页> 外文期刊>BMC Neurology >New multiplex real-time PCR approach to detect gene mutations for spinal muscular atrophy
【24h】

New multiplex real-time PCR approach to detect gene mutations for spinal muscular atrophy

机译:新的多重实时PCR方法检测脊髓性肌萎缩症的基因突变

获取原文

摘要

Background Spinal muscular atrophy (SMA) is the most common autosomal recessive disease in children, and the diagnosis is complicated and difficult, especially at early stage. Early diagnosis of SMA is able to improve the outcome of SMA patients. In our study, Real-time PCR was developed to measure the gene mutation or deletion of key genes for SMA and to further analyse genotype-phenotype correlation. Methods The multiple real-time PCR for detecting the mutations of survival of motor neuron ( SMN ), apoptosis inhibitory protein ( NAIP ) and general transcription factor IIH, polypeptide 2 gene ( GTF2H2 ) was established and confirmed by DNA sequencing and multiplex ligation-dependent probe amplification (MLPA). The diagnosis and prognosis of 141 hospitalized children, 100 normal children and further 2000 cases of dry blood spot (DBS) samples were analysed by this multiple real-time PCR. Results The multiple real-time PCR was established and the accuracy of it to detect the mutations of SMN , NAIP and GTF2H2 was at least 98.8?% comparing with DNA sequencing and MLPA. Among 141 limb movement disorders children, 75 cases were SMA. 71 cases of SMA (94.67?%) were with SMN c.840 mutation, 9 cases (12?%) with NAIP deletion and 3 cases (4?%) with GTF2H2 deletion. The multiple real-time PCR was able to diagnose and predict the prognosis of SMA patients. Simultaneously, the real-time PCR was applied to detect trace DNA from DBS and able to make an early diagnosis of SMA. Conclusion The clinical and molecular characteristics of SMA in Southwest of China were presented. Our work provides a novel way for detecting SMA in children by using real-time PCR and the potential usage in newborn screening for early diagnosis of SMA.
机译:背景脊髓性肌萎缩症(SMA)是儿童中最常见的常染色体隐性遗传疾病,诊断复杂且困难,尤其是在早期阶段。 SMA的早期诊断能够改善SMA患者的预后。在我们的研究中,开发了实时荧光定量PCR以测量SMA的基因突变或关键基因的缺失,并进一步分析基因型与表型的相关性。方法建立多重实时荧光定量PCR检测运动神经元(SMN),凋亡抑制蛋白(NAIP)和通用转录因子IIH,多肽2基因(GTF2H2)的存活突变,并通过DNA测序和多重连接依赖性证实探针扩增(MLPA)。通过这种多重实时PCR分析了141例住院儿童,100例正常儿童以及另外2000例干血斑(DBS)样本的诊断和预后。结果建立了多重实时荧光定量PCR,与DNA测序和MLPA相比,其检测SMN,NAIP和GTF2H2突变的准确性至少为98.8%。在141名肢体运动障碍儿童中,有75例为SMA。 SMN c.840突变的SMA患者为71例(94.67%),NAIP缺失的为9例(12%),GTF2H2缺失的为3例(4%)。多重实时PCR能够诊断和预测SMA患者的预后。同时,采用实时荧光定量PCR检测DBS中的痕量DNA,并能对SMA进行早期诊断。结论介绍了西南地区SMA的临床和分子特征。我们的工作提供了一种通过实时PCR检测儿童SMA的新颖方法,以及在新生儿筛查SMA的早期诊断中的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号